Related to this topic: Patient+ | Equipment | Books | Your Experience | Other resources | Glossaries
Print options: Printer friendly version of this leaflet (html)     Other options:  AddThis Social Bookmark Button (what's this?)

PatientPlus articles are written for doctors and so the language can be technical. However, some people find that they add depth to the articles found in the other sections of this website which are written for non-medical people.

Rheumatoid Factor

Rheumatoid factor is an antibody against the Fc portion of IgG (also an antibody). They can belong to any isotype of immunoglobulin e.g. IgM, IgG and IgE - and any of these can be detected in the blood test.1

When to measure

Any patient who may have arthritis. But keep in mind it may be negative in rheumatoid disease. Many are seronegative to begin with but 80% seroconvert (become positive).2 Disease severity is often worse in those who are seropositive.3

How to measure

Venous blood taken in clotted tube - usually same one as U + E.

How are the results reported

Results can be reported in titres (normal < 1:20) but more commonly as units and <23u is normal (normal levels may vary from laboratory to laboratory). The sensitivity and specificity of rheumatoid factor for rheumatoid disease is low and thus it is not a good screening test. However, the predictive value of rheumatoid factor in patients with symmetric polyarticular joint swelling is 80%.

When is it positive
  1. Significant associations - rheumatoid disease, Felty's syndrome. The higher the level in rheumatoid disease the more worse the joint destruction and greater chance of systemic involvement.
  2. Insignificant associations - any inflammatory condition e.g. Sjogrens disease, systemic lupus erythematous and mixed connective tissue disorder (see table).

Disease associations of rheumatoid factor4,1

  • Rheumatoid arthritis 70-80%
  • Sjogrens syndrome ≤100 %
  • Felty's syndrome ≤100 %
  • Systemic sclerosis 30%
  • Infective endocarditis ≤ 50%
  • Systemic lupus erythematous ≤ 40%
  • Infectious mononucleosis
  • Hepatitis
  • Juvenile rheumatoid arthritis
  • Tuberculosis
  • Dermatomyositis
  • Syphillis
  • HIV
  • Influenza
  • Malignancy
  • Sarcoidosis
  • Leukaemia
  • Healthy individuals 1-2% - increasing to 20% over age of 65 years

Prognostic use of rheumatoid factor

Rheumatoid factor does not generally help in monitoring disease - although it may help with the use of the newer agents etanercept and infliximab. In patients on etanercept or infliximab and disease modifying antirheumatic drugs the levels of rheumatoid factor reduces which is associated with reduced clinical disease activity.5,6

It can predict disease outcome in some patients1, one example of this is that radiological progression i.e. changes in hand x rays are worse in those who are seropositive.7


Document References
  1. Wilson D; Rheumatoid factors in patients with rheumatoid arthritis. Can Fam Physician. 2006 Feb;52:180-1.
  2. Pincus T; Advantages and limitations of quantitative measures to assess rheumatoid arthritis - joint counts, radiographs, laboratory tests, and patient. Bull Hosp Jt Dis. 2006;64(1-2):32-9. [abstract]
  3. Shin YS, Choi JH, Nahm DH, et al; Rheumatoid factor is a marker of disease severity in Korean rheumatoid arthritis. Yonsei Med J. 2005 Aug 31;46(4):464-70. [abstract]
  4. Longmore, M., Wilkinson, I.B. and Rajagopalan, S.R. (2004): Oxford Handbook of Clinical Medicine, 6th ed, OUP
  5. Chen HA, Lin KC, Chen CH, et al; The effect of etanercept on anti-cyclic citrullinated peptide antibodies and rheumatoid factor in patients with rheumatoid arthritis. Ann Rheum Dis. 2006 Jan;65(1):35-9. Epub 2005 Jun 23. [abstract]
  6. De Rycke L, Verhelst X, Kruithof E, et al; Rheumatoid factor, but not anti-cyclic citrullinated peptide antibodies, is modulated by infliximab treatment in rheumatoid arthritis. Ann Rheum Dis. 2005 Feb;64(2):299-302. Epub 2004 May 27. [abstract]
  7. Vittecoq O, Pouplin S, Krzanowska K, et al; Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients. Rheumatology (Oxford). 2003 Aug;42(8):939-46. Epub 2003 Apr 16. [abstract]
Acknowledgements EMIS is grateful to Dr Gurvinder Rull for writing this article. The final copy has passed scrutiny by the independent Mentor GP reviewing team. ©EMIS 2007.
DocID: 6924
Document Version: 1
DocRef: bgp26049
Last Updated: 23 Mar 2007
Review Date: 22 Mar 2009


















Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site










Disclaimer: Patient UK has no control of the content of the above links. Inclusion does not imply endorsement by Patient UK.

Advertise on this site


PS - Health and Poverty

Perhaps the biggest cause of ill health in the world is poverty. Help to Make Poverty History. For example, why not lend some of your money to disadvantaged communities to enable them to trade their way out of poverty through schemes such as Shared Interest.

See also MAKEPOVERTYHISTORY North East for details and links to campaigns against poverty.

^ Top of Page